Status:

UNKNOWN

SafeTy and Efficacy of Preventative CoVID Vaccines

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Conditions:

COVID-19 Virus Infection

Vaccine Response

Eligibility:

All Genders

30+ years

Brief Summary

The STOPCoV study is a decentralized study comparing COVID-19 vaccine specific antibody levels at 24 weeks after final vaccine dose. We plan to study the safety and immunogenicity of COVID-19 vaccine(...

Detailed Description

This is a prospective observational study of a cohort of individuals aged 30-50 years and a cohort of individuals aged 70 years and over receiving the COVID-19 vaccine. Participants will complete a q...

Eligibility Criteria

Inclusion

  • Must be a resident of Ontario
  • Arm A:
  • Individuals aged 70 and over
  • Speak, read and understand English (or have a trusted individual to help with study procedures)
  • Will receive a first or second dose of a COVID-19 vaccine at an Ontario vaccine distribution center. Individuals reaching the minimum age requirement by end of the recruitment calendar year are allowed to participate.
  • Arm B:
  • Individuals between age 30-50 years
  • Speak, read and understand English (or have a trusted individual to help with study procedures)
  • Receive a first or second dose of a COVID-19 vaccine at an Ontario vaccine distribution center.

Exclusion

  • Not a resident of Ontario
  • Individuals who are \< 30 years or those 51-69 years.
  • Those who are unable to complete the study protocols in English either alone or with the assistance of a trusted individual with an electronic device.
  • Participants who do not receive any dose of the vaccine
  • Participants who have already received both doses of the vaccine prior to enrolment.

Key Trial Info

Start Date :

May 6 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2024

Estimated Enrollment :

1286 Patients enrolled

Trial Details

Trial ID

NCT05208983

Start Date

May 6 2021

End Date

April 1 2024

Last Update

January 5 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Network

Toronto, Ontario, Canada, M5G 2C4